Republican lawmakers are working behind closed doors to convince the Senate parliamentarian—the chamber’s unelected rules arbiter—to tank Democrats’ watered-down but still potentially impactful proposal to require Medicare to negotiate the prices of a small number of prescription drugs directly with pharmaceutical companies. Sen. Mike Crapo, R-Idaho, a major beneficiary of pharmaceutical industry campaign cash, admitted as much in remarks to reporters on Tuesday, saying that he and his GOP colleagues are “going through line by,
from Salon
